Course InformationTherapautic Area: Pulmonolgy
Credit(s): 2.00 AMA PRA Category 1 Credit(s)™
Activity Dates: January 10, 2017 - January 9, 2018
The content for this activity is based on the satellite symposium, “Applying Recent Advances in the Science of CFTR-based Therapeutics to Improve Outcomes in Patients With Cystic Fibrosis”, that was presented at the 30th Annual North American Cystic Fibrosis Conference in Orlando, Florida on October 28, 2016. The content highlights the latest advancements, particularly in CFTR-based therapeutics, for the treatment of patients with cystic fibrosis. Expert faculty discuss the most up-to-date analysis for clinical decision-making, including updates on assessment, monitoring, and management of patients treated with CFTR modulator therapies. The goal of this activity is to increase the knowledge and competencies of the multidisciplinary team involved in the management of patients with CF, and provide strategies for improving the lives of patients. Upon completion of this activity, healthcare providers will be better equipped with imperative information for creating more effective personalized treatment plans and improving patient outcomes.
This activity is designed for physicians, nurses, and other healthcare professionals involved in the management of patients with cystic fibrosis.
- Review and analyze the current clinical trial data for CFTR modulator therapeutics to develop effective individualized treatment plans.
- Discuss the details of real-world outcomes for patients treated with CFTR-based therapeutics.
- Apply the principles of early diagnosis and early pharmaco-therapeutic intervention to the pediatric cystic fibrosis population.
- Understand the science of developing therapeutic options for treating a larger population of cystic fibrosis patients.
JP Clancy, MD (Chair)
Professor and Gunnar Esiason/Cincinnati Bell Chair
Director, Pulmonary Medicine Research
Medical Director, Office of Clinical and Translational Research
Cincinnati Children’s Hospital Medical Center
Steven M. Rowe, MD
Professor, Department of Medicine, Pediatrics, and Cell Developmental & Integrative Biology
Director, Gregory Fleming James
Cystic Fibrosis Research Center
Gwaltney Endowed Chair Medical Research
University of Alabama at Birmingham
This activity is expired for CE Credit
Co-provided by the Elsevier Office of Continuing Medical Education and AcademicCME.
This CME activity has been supported by an independent educational grant from Vertex Pharmaceuticals Incorporated.